Search research articles
Contact Us
Filters
Showing results (381-390 of 443) with videos related to
Page
of 45
Sort By:
Nature Medicine
|
December 18, 2020
T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a phase 1/2 clinical trial
Katie J Ewer, Jordan R Barrett, Sandra Belij-Rammerstorfer, et al.
Science (New York, N.Y.)
|
March 3, 2012
Global network reorganization during dynamic adaptations of Bacillus subtilis metabolism
Joerg Martin Buescher, Wolfram Liebermeister, Matthieu Jules, et al.
Science (New York, N.Y.)
|
March 3, 2012
Condition-dependent transcriptome reveals high-level regulatory architecture in Bacillus subtilis
Pierre Nicolas, Ulrike Mäder, Etienne Dervyn, et al.
The Lancet. Child & Adolescent Health
|
March 16, 2023
Development of treatment-decision algorithms for children evaluated for pulmonary tuberculosis: an individual participant data meta-analysis
Kenneth S Gunasekera, Olivier Marcy, Johanna Muñoz, et al.
Nature Medicine
|
May 7, 2021
Author Correction: Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses
Jordan R Barrett, Sandra Belij-Rammerstorfer, Christina Dold, et al.
Nature Medicine
|
December 18, 2020
Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses
Jordan R Barrett, Sandra Belij-Rammerstorfer, Christina Dold, et al.
Nature
|
April 27, 2022
Author Correction: Expanded encyclopaedias of DNA elements in the human and mouse genomes
, Jill E Moore, Michael J Purcaro, et al.
Nature
|
July 31, 2020
Expanded encyclopaedias of DNA elements in the human and mouse genomes
, Jill E Moore, Michael J Purcaro, et al.
Lancet (London, England)
|
April 2, 2021
Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012/01 (B.1.1.7): an exploratory analysis of a randomised controlled trial
Katherine R W Emary, Tanya Golubchik, Parvinder K Aley, et al.
Lancet (London, England)
|
November 22, 2020
Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial
Maheshi N Ramasamy, Angela M Minassian, Katie J Ewer, et al.
Page
of 45
Search research articles
Search
Showing results (381-390 of 443) with videos related to
Sort By:
Page
of 45
Nature Medicine
|
December 18, 2020
T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a phase 1/2 clinical trial
Katie J Ewer, Jordan R Barrett, Sandra Belij-Rammerstorfer, et al.
Science (New York, N.Y.)
|
March 3, 2012
Global network reorganization during dynamic adaptations of Bacillus subtilis metabolism
Joerg Martin Buescher, Wolfram Liebermeister, Matthieu Jules, et al.
Science (New York, N.Y.)
|
March 3, 2012
Condition-dependent transcriptome reveals high-level regulatory architecture in Bacillus subtilis
Pierre Nicolas, Ulrike Mäder, Etienne Dervyn, et al.
The Lancet. Child & Adolescent Health
|
March 16, 2023
Development of treatment-decision algorithms for children evaluated for pulmonary tuberculosis: an individual participant data meta-analysis
Kenneth S Gunasekera, Olivier Marcy, Johanna Muñoz, et al.
Nature Medicine
|
May 7, 2021
Author Correction: Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses
Jordan R Barrett, Sandra Belij-Rammerstorfer, Christina Dold, et al.
Nature Medicine
|
December 18, 2020
Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses
Jordan R Barrett, Sandra Belij-Rammerstorfer, Christina Dold, et al.
Nature
|
April 27, 2022
Author Correction: Expanded encyclopaedias of DNA elements in the human and mouse genomes
, Jill E Moore, Michael J Purcaro, et al.
Nature
|
July 31, 2020
Expanded encyclopaedias of DNA elements in the human and mouse genomes
, Jill E Moore, Michael J Purcaro, et al.
Lancet (London, England)
|
April 2, 2021
Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012/01 (B.1.1.7): an exploratory analysis of a randomised controlled trial
Katherine R W Emary, Tanya Golubchik, Parvinder K Aley, et al.
Lancet (London, England)
|
November 22, 2020
Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial
Maheshi N Ramasamy, Angela M Minassian, Katie J Ewer, et al.
Page
of 45